Aug 26, 2020
We talk with Dr. Michael Brant-Zawadzki and Dr. Burton Eisenberg Hoag is First in Nation to Test Innovative Antibody Brain Cancer Drug; clinical trial for a novel immunotherapy treatment that holds considerable promise for glioblastoma (GBM), the deadliest form of brain cancer; Hoag's research and clinical trials.
To...
Aug 19, 2020
Listen as we talk to Dr. Taglietti about SCYNEXIS and their drug Ibrexafungerp
The press release below talks about their successful meeting with the NDA- https://ir.scynexis.com/press-releases/detail/216/scynexis-reports-successful-completion-of-pre-nda-meetings recently for Ibrexafungerp for the treatment of VVC, the...
Aug 5, 2020
In this episode of TrialSite News Podcast we speak with Dr. Theresa Deisher about supercharging the body's own natural immune response; a potential solution to global pandemics, no-option cancers, and auto-immunity.
AVM Biotechnology's lead product, AVM0703, is based on a repurposed active ingredient (Dexamethasone)...